A comprehensive study to evaluate the effect of constant low voltage iontophoresis on transungual delivery.
Treatment of nail diseases by topical drug delivery continues to draw much attention in the recent days. This study aims to systematically investigate the effect of constant voltage iontophoresis in the transungual drug delivery, using ciclopirox as a model drug. Preliminary permeation studies were carried out by applying constant voltage (6 V for 24 h) using a gel formulation across the human nail plate in a Franz diffusion cell. Different protocols have been studied to authenticate the potential of the proposed technique. Antifungal studies were carried out to assess the pharmacodynamic effect of drug depot formed in the nail plate. Initial studies revealed that application of constant voltage iontophoresis enhanced the permeation by an order of magnitude (p = 0.019) and delivered significant amount of drug into the deeper nail layers. Noticeably higher permeation was observed during the active phase in on-off studies. Excellent correlation was observed in permeation (r(2) = 0.98) and drug load (r(2) = 0.97) with the increase in applied voltage (3-12 V), indicating that the current technique is predictable. The data observed suggest that any further increase in voltage could eventually lead to increase in the permeation and drug load, as the saturation level is very distant. Furthermore, the enhancement in permeation with the applied voltage (3-12 V) was found to be 6-20 folds, compared to the passive process. Results of step up and step down studies substantiated the viability of the current technique. Zone of inhibition measured during the antifungal studies demonstrated that the drug molecules loaded into the nail plate by low voltage iontophoresis is active and releases over an extended period of time (~32 days). Given the excellent results, the current technique could be used as an effective approach for the delivery of antimycotics, which would localize the drug at the infection site and potentially offer higher patient compliance.
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, KSA. banroop@gmail.com
Anroop B
AB
Nair
Kishan
K
Singh
Pottathil
P
Shinu
Sree
S
Harsha
Bandar E
BE
Al-Dhubiab
D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000494:pharmacology; D000077768:Ciclopirox; D016503:Drug Delivery Systems; D005782:Gels / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D007478:Iontophoresis / Q000379:methods; D009260:Nail Diseases / Q000188:drug therapy*; D009262:Nails / Q000187:drug effects*; D010539:Permeability / Q000187:drug effects; D011728:Pyridones / Q000008:administration & dosage* / Q000737:chemistry / Q000494:pharmacology
D000935:Antifungal Agents; D005782:Gels; D011728:Pyridones; D000077768:Ciclopirox